Connection

Loreto Gesualdo to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Loreto Gesualdo has written about Antibodies, Monoclonal, Humanized.
Loreto Gesualdo
Connection Strength
0.046
Antibodies, Monoclonal, Humanized
  1. Treatment of COVID-19 atypical pneumonia by early Tocilizumab administration in "non-critically-ill" patients on hemodialysis. J Nephrol. 2021 02; 34(1):259-262.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.